Cocrystal Pharma Announces Key Advance Coronavirus Program
Cocrystal Pharma Inc. (NASDAQ: COCP) rallied by more than 50% after confirming the initiation of a coronavirus program. The clinical-stage biotechnology company has already inked a strategic partnership with Kansas State University Research Foundation. The strategic partnership will seek to explore the suitability of certain antiviral compounds in the treatment of norovirus and coronavirus infections.
The company has already acquired patent rights as well as know-how from KSURF as it moves to kick start the coronavirus program. The ultimate goal is to advance the program into preclinical development to address the growing threat of COVID1-19
“Following our acquisition of patent rights and know-how from KSURF and our recently completed financing, we are aggressively pursuing the development of novel antiviral compounds for the treatment of Coronavirus infections using our established proprietary drug discovery platform,” said Chief Executive Officer, Gary Wilcox.
The push to come up with treatments for coronavirus has helped strengthen the stock’s sentiments in the market at a time when there is no known treatment for the havoc causing virus. Similarly, the stock has exploded in the market and showing signs of powering high even further.
CBD Unlimited Inc. (OTC: EDXC) is another stock showing signs of powering high in the burgeoning cannabis industry. The company is increasingly making a name for itself on the development of CBD products made from hemp extracts and contains less than 0.3% THC.
CBD Unlimited Inc. (OTC: EDXC) boasts of a robust portfolio of CBD products made up of oils as well as capsules, tropical, and pet products. Phyto-Bites are CBD Unlimited Inc’s (OTC: EDXC) flagship CBD products, a CBD based chew for animals. Similarly, the company has curbed a niche for itself on the development of CBD products for addressing pain as well as anxiety and inflammation.
CBD Unlimited Inc. (OTC: EDXC) has since embarked on an aggressive marketing campaign as it looks to make its products available in more than 2,000 stores. The long term plan is to ink deals with more than 50,000 stores across the country. International expansion should also follow suit CBD Unlimited Inc. (OTC: EDXC) having already secured permission to distribute its products in Puerto Rico and South Africa.
Source: Stock Market Press
Join Stock Market Press’ newsletter for the latest in IPO, market commentary and company profiles.
Stock Market Press is a financial news company that delivers up to date stock news, introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network.
Contact:
Stock Market Press
110 Wall St.
New York, NY 10005 info@stockmarketpress.com
Safe Harbor Statement:
Statements in this news release may be ”forward-looking statements.” Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Stock Market Press undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.
See Stock Market Press disclaimer: https://stockmarketpress.com/disclaimer/ SOURCE: Stock Market Press
